Steroid withdrawal in lung transplant recipients

被引:23
|
作者
Borro, JM
Solé, A
De la Torre, M
Pastor, A
Tarazona, V
机构
[1] Hosp Juan Canalejo, La Coruna 15006, Spain
[2] Hosp Univ La Fe, Valencia, Spain
[3] Hosp Clin Univ Valencia, Coruna, Spain
关键词
D O I
10.1016/j.transproceed.2005.09.190
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. Many of the long-term complications in lung transplantations are secondary effects of immunosuppression. Corticosteroids are partially responsible for the development of osteoporosis, raised blood pressure, diabetes, muscular disorders, gastric ulcers, and other conditions. We analyzed the long-term result of steroid withdrawal in our lung transplant recipients. Materials and methods. When respiratory function stabilized, to avoid secondary effects, steroid treatment was withdrawn in 34 of the 375 lung transplant patients in our centers We evaluated the characteristics of the donors and recipients, their compatibility, the pre, and post-steroid withdrawal complications, and type of immunosuppressant. Results. The mean age of patients was 42 +/- 7 years and of donors, 25 9 years. The primary diseases were: 15 emphysema, six pulmonary fibrosis, 10 cystic fibrosis, and three primary pulmonary hypertension. Twenty seven patients had double lung transplants and seven single lung. The mean steroid withdrawal period was 881 +/- 237 days posttransplantation. The most frequent treatment regimen at the time of steroid withdrawal was cyclosporine, azathioprine, and minimal steroid doses. Six recipients had to be restarted on steroids one patient who required a kidney transplant, three cases due to an infectious process with a differential diagnosis of rejection, and two cases due to loss of FEV1 (forced expiratory volume in 1 s), suggestive of chronic rejection. There was an improvement in blood pressure in five patients, in plasma cholesterol and triglyceride levels in eight patients, and insulin withdrawal in two diabetic patients. Conclusions. Steroid treatment may be suspended 2 to 3 years, posttransplant in selected lung transplant recipients. The usual patient profile shows few rejection episodes with cyclosporine and azathioprine immunosuppression. What is notable is the low mean age of donors. Close clinical monitoring and lung function testing are of major importance in the weeks following steroid withdrawal.
引用
收藏
页码:3991 / 3993
页数:3
相关论文
共 50 条
  • [1] Steroid withdrawal in pancreas transplant recipients
    Humar, A
    Parr, L
    Drangstveit, MB
    Gruessner, A
    Sutherland, DER
    TRANSPLANTATION, 1999, 67 (07) : S208 - S208
  • [2] Steroid withdrawal in pancreas transplant recipients
    Humar, A
    Parr, E
    Drangstveit, MB
    Kandaswamy, R
    Gruessner, AC
    Sutherland, DER
    CLINICAL TRANSPLANTATION, 2000, 14 (01) : 75 - 78
  • [3] Steroid withdrawal in renal transplant recipients
    Oppenheimer, F
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (1A) : 14S - 15S
  • [4] Steroid withdrawal in renal transplant recipients
    Ponticelli, C
    Tarantino, A
    Montagnino, G
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 987 - 988
  • [5] Successful steroid withdrawal in lung transplant recipients: result of a pilot study
    Shitrit, D
    Bendayan, D
    Sulkes, J
    Shitrit, ABG
    Huerta, M
    Kramer, MR
    RESPIRATORY MEDICINE, 2005, 99 (05) : 596 - 601
  • [6] Steroid avoidance or withdrawal for kidney transplant recipients
    Pascual, Julio
    Zamora, Javier
    Galeano, Cristina
    Royuela, Ana
    Quereda, Carlos
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [7] Steroid avoidance or withdrawal for kidney transplant recipients
    Haller, Maria C.
    Royuela, Ana
    Nagler, Evi V.
    Pascual, Julio
    Webster, Angela C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (08):
  • [8] Late steroid withdrawal in kidney transplant recipients
    Vila, A
    Ricart, MJ
    Vilardell, JV
    Torregrossa, F
    Cofan, JM
    Campistol, F
    Oppenheimer, F
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (08) : 2634 - 2635
  • [9] Steroid withdrawal in pediatric liver transplant recipients
    Yoshida, A
    Brady, L
    Cronin, D
    Kelly, S
    Siegel, C
    Woodle, ES
    Millis, JM
    TRANSPLANTATION, 1999, 67 (07) : S180 - S180
  • [10] Steroid withdrawal in nonimmunologically selected heart transplant recipients
    Sánchez, V
    Delgado, JE
    Gómez, MA
    Escribano, P
    Dalmau, R
    Pombo, M
    Gil, L
    Sotelo, T
    Rodríguez, E
    de la Calzada, C
    de la Calzada, S
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 164 - 165